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Shiga toxin-producing Escherichia coli (STEC) can cause central nervous system
(CNS) damage resulting in paralysis, seizures, and coma. The key STEC virulence
factors associated with systemic illness resulting in CNS impairment are Shiga toxins
(Stx). While neurons express the Stx receptor globotriaosylceramide (Gb3) in vivo,
direct toxicity to neurons by Stx has not been studied. We used murine neonatal
neuron cultures to study the interaction of Shiga toxin type 2 (Stx2) with cell
surface expressed Gb3. Single molecule imaging three dimensional STochastic Optical
Reconstruction Microscopy—Total Internal Reflection Fluorescence (3D STORM-TIRF)
allowed visualization and quantification of Stx2-Gb3 interactions. Furthermore, we
demonstrate that Stx2 increases neuronal cytosolic Ca2+, and NMDA-receptor
inhibition blocks Stx2-induced Ca2+ influx, suggesting that Stx2-mediates glutamate
release. Phosphoinositide 3-kinase (PI3K)-specific inhibition by Wortmannin reduces
Stx2-induced intracellular Ca2+ indicating that the PI3K signaling pathway may be
involved in Stx2-associated glutamate release, and that these pathways may contribute
to CNS impairment associated with STEC infection.
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Introduction
Shiga toxin-producing Escherichia coli (STEC) infection is an important cause of food poisoning,
often associated with contaminated beef and leafy vegetables. STEC associated disease can include
diarrhea, bloody diarrhea, hemolytic uremic syndrome (HUS), as well as central nervous system
(CNS) impairment. More than 175,000 people per year in the USA are estimated to be infected
by STEC (Scallan et al., 2011), and studies have shown the frequency of CNS manifestation to be
as high as 42% among STEC-HUS patients (Cimolai et al., 1992; Siegler et al., 1994; Verweyen
et al., 1999; Gerber et al., 2002; Oakes et al., 2006; Iijima et al., 2008), such as cortical blindness,
poor fine-motor coordination, seizures, and changes in consciousness including coma, indicating
a broad spectrum CNS impact. Also, CNS manifestations are often associated with mortality
or severe sequelae with the mortality rate of HUS patients showing CNS signs/symptoms being
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two- to three-fold higher than that of HUS alone (Bale et al.,
1980; Upadhyaya et al., 1980; Brasher and Siegler, 1981; Sheth
et al., 1986; Cimolai et al., 1992; Siegler, 1994; Siegler et al., 1994).
Importantly, CNS symptoms that appear prior to or in absence
of HUS have been reported following STEC infection (Bale et al.,
1980; Upadhyaya et al., 1980; Brasher and Siegler, 1981; Taylor
et al., 1986; Siegler, 1994). In 2011, a European outbreak of STEC
resulted in more than 4000 infections with the highest recorded
percentage of HUS (22%) (Werber et al., 2013). Furthermore,
the outbreak was associated with rather frequent and severe
levels of neurological symptoms. To illustrate this, in one cohort,
104 of 217 patients with complicated STEC infection developed
neurological manifestations (Magnus et al., 2012). This outbreak
was caused by a unique STEC strain with enteroaggregative
properties but with the ability to express stx2 (Jandhyala et al.,
2013). This outbreak alerts us both to the potential impact of
new emerging infectious diseases, as well as to the importance of
STEC-associated CNS disease. The mechanism(s) by which Stx2
promotes neurological symptoms is poorly understood. To date,
no specific therapy is available for prevention or remediation of
STEC-associated CNS complications emphasizing the need for a
better understanding of Stx2-associated CNS impairment.
Various Stx2-associated animal models with CNS symptoms
have been reported, including those using pigs, rabbits, rats, or
mice (Tzipori et al., 1988; Fujii et al., 1996; Mizuguchi et al.,
1996; Sugatani et al., 2000; Garcia et al., 2008; Obata et al., 2008;
Takahashi et al., 2008; Tironi-Farinati et al., 2010). Among them,
the most common neurological symptom is hindlimb paralysis
(Tzipori et al., 1988; Fujii et al., 1996; Mizuguchi et al., 1996;
Sugatani et al., 2000; Garcia et al., 2008; Obata et al., 2008;
Takahashi et al., 2008; Tironi-Farinati et al., 2010; Obata and
Obrig, 2014). In mice, unilateral hindlimb paralysis is seen after
Stx2 injection (Obata et al., 2008) that partially resembles to
hemiparesis and hemiplegia of STEC-patients. Moreover, we
reported that both human and mouse CNS neurons display the
Stx2 receptor globotriaosyl ceramide (Gb3) and Stx2 and Gb3
can be detected in lumbar spinal cord motor neurons in Stx2-
injected mice (Obata et al., 2008). However, the direct interaction
of Stx2 with neurons and the effect of the toxin on neurons
have not been investigated in vitro in any mechanistic detail.
In this article, we used murine postnatal neuronal cultures to
investigate the binding of Stx2 via receptor Gb3 expressed on
the surface of the cells. Moreover, we determined that Stx2




Timed pregnant female C57BL/6 and 4–6 week old male
C57BL/6 mice were purchased from Charles River laboratories
(Wilmington, MA, USA). Mice were housed with a 12/12 h
light and dark cycle and given access to food and water
ad libitum until the birth of neonates or the end of the
experiments. On the day of birth, the mother is separated from
neonates and euthanized. For in vivo studies of adult mice, male
mice were injected intraperitoneally with 400 ng/kg Stx2. To
harvest CNS tissues, mice were euthanized with CO2 inhalation
and perfused with saline from the heart, followed by 4%
paraformaldehyde (Sigma-Aldrich, St. Louis, MO) in phosphate
buffered saline (HyClone/ThermoFisher Scientific, Waltham,
MA) (4% PFA/PBS). Brains and spinal cords were harvested. All
animal procedures were performed under an animal use protocol
that was reviewed and approved by the Institutional Animal
Care and Use Committee at University of Maryland School of
Medicine Office of Animal Welfare Assurance (IACUC protocol
#0811012). The animal use protocol complies with the Animal
Welfare Act, Public Health Service Policy on Humane Care and
Use of Laboratory Animals and the Guide for the Care and Use
of Laboratory Animals.
Cell Cultures
The hippocampal neuronal cultures were made from post
natal day 0 (P0) mouse brain using neurobasal-A media
without phenol red (Gibco/Life Technologies, Grand Island,
NY) supplemented with 0.5mM L-glutamine, 50U/ml penicillin,
50µg/ml streptomycin, 1X B27 according to the manufacture’s
instruction. Cells were seeded on poly-L-lysine (Sigma-Aldrich)-
coated glass bottom petri dishes (MatTek, Ashland, MA) at 1 ×
104 cells per dish for imaging experiments and on lysine-coated
100mm diameter plastic dishes at 2× 106 cells per dish for lysate
experiments. Day in vitro 1 (DIV1) is defined as the day the
tissue culture was started. On DIV4 a half of the culture volume
was replaced with fresh culture media. DIV7 cultures were
used for experiments. Vero cells were purchased from American
Type Culture Collection (ATCC, Manassas, VA) and maintained
in RPMI1640 media (Gibco/Life Technologies) supplemented
with 10% fetal bovine serum (HyClone/ThermoFisher Scientific),
1mM L-glutamine (Cellgro/Mdiatech, Manassas, VA) and
100U/ml penicillin and 100µg/ml streptomycin (Gibco/Life
Technologies).
Purification of Stx2 with LPS Removal
Purification of Stx2 was kindly provided by Dr. Anne Kane
(The Phoenix Lab at Tufts Medical Center, Boston, MA)
(Donohue-Rolfe et al., 1989; Stone et al., 2012). LPS was
removed from purified Stx2 by Detoxi-gel from Thermo Fisher
Scientific (Rockford, IL, USA) as per the manufacturer’s protocol.
A phosphate-buffered saline (PBS)-eluted and 0.2µm filter
sterilized Stx2 fraction was tested for LPS [<0.03 endotoxin
unit (EU)/ml] using the Limulus amebocyte lysate (LAL) assay
(Pyrotell, Associates of Cape Cod Incorporated, East Falmouth,
MA, USA). Stx2 fraction was LPS negative in this LAL assay.
Immunofluorescence of Stx2-treated Cells
Cells were incubated with 20 nM Stx2 at 37◦C for 5 or 15min,
or with medium alone (0 nM Stx2 control). At the end of the
incubation, dishes were placed on ice to stop the internalization
of Stx2 and washed with ice cold PBS, for 5min. Cells were
fixed with 4% PFA/PBS, washed and blocked with 3% bovine
serum albumin (BSA, Sigma-Aldrich) in PBS. Cells were not
permeabilized in order to promote detection of antigen on the
cell surface. Cells were treated with anti-Gb3 rat monoclonal
antibody (clone 38-13, Immunotec/Beckman Coulter, Brea,
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CA) diluted (1:100) in 1% BSA/PBS incubation at 4◦C for
overnight, followed by washing in PBS and adding anti-rat IgM-
AlexaFluor488 (Life Technologies) diluted (1:2000) in PBS and
incubated at room temperature for 2 h. After washing, cells
were incubated with anti-Stx2A mouse monoclonal antibody
(11E10, ATCC) diluted in 1% BSA/PBS at 4◦C for overnight,
followed by washing in PBS and treating with anti-mouse IgG-
AlexaFluor647 (Life Technologies) at room temperature for 2 h.
Cells were washed again in PBS and nuclei were stained with 4′,6-
diamidino-2-phenylindole (DAPI, Life Technologies). Duplicate
samples were prepared, one for confocal microscopy and the
other for three dimensional STochastic Optical Reconstruction
Microscopy—Total Internal Reflection Fluorescence microscope
(3D STORM-TIRF) observation. Samples were kept in PBS at
4◦C until microscopic observation.
Confocal Microscopy
Confocal microscopy was performed using a LSM510 (Carl
Zeiss, Thornwood, NY) with Argon (488 nm, 25mW), Helium
Neon (633 nm, 6mW) and Mai Tai (710 nm, 2 photon
excitation for DAPI, 1.5W) lasers to visualize AlexaFluor-
488, -647, and DAPI, respectively. In addition, differential
interference contrast microscopy (DIC) was also performed.
Image acquisition and analysis were performed using the LSM 5
Image Browser. Confocal experiments were performed using the
confocal microscopy facility at University of Maryland School of
Medicine.
Three Dimensional STORM-TIRF
Buffer of the stained cells was changed from PBS to STORM-
imaging buffer [50mM Tris-HCl (pH 8.0), 10mM NaCl, 10%
glucose, 5.6mg/ml glucose oxidase, 0.17mg/ml catalase, 100mM
MEA (cysteamine), all from Sigma-Aldrich] right before the
imaging and kept in the same buffer during the imaging. 256 ×
256 pixel fields comprising approximately one cell per field were
imaged individually. A TIRF degree of 2660 was used with the
perfect focus 3D STORM setting upon sample bleaching for the
certain angles just below and above of the indicated TIRF angle
of interest. The sample bleaching eliminates non-specific signals
and provides the true signals of the designated fluorophores.
Argon (488 nm) and Helium Neon (647 nm) lasers were used
at 100% power at acquisition in order to activate all possible
fluorescencemolecules and provide themaximum for the specific
signal of interest. A total of 10,000 events were collected per
image. Nikon NIS-Elements software was used to acquire and
analyze collected STORM-TIRF images. The diameter of one
fluorescence molecule was 10 nm. Twelve 488 (Gb3)/647 (Stx2)
double positive clusters were measured for the size in molecules.
The 488 cluster size was calculated as 39.25 ± 14.97 fluorescence
molecules per cluster and the 647 cluster size was calculated as
42.83 ± 17.93 fluorescence molecules per cluster. Fluorescence
signals smaller than these sizes were eliminated as noises. An
entire cell was optically sectioned in 50 nm z-steps (z-slices) with
the range being between −500 and +500 nm that corresponds
to between extracellular and intracellular depths. Then, 488/647
double positive objects that fulfilled intensity and area size of the
Gb3 and Stx2 positive clusters in each z-slice were accordingly
counted in order to quantify colocalization. Cells were visualized
with 100 X magnification. Acquisition and analysis of 3D
STORM-TIRF experiments were performed at The Institute of
Human Virology Imaging facility at the University of Maryland
School of Medicine.
Live Cell Calcium Dye Imaging
Neuronal cultures at DIV7 were treated with a low affinity Ca2+-
binding, cell-permeable dye fluo-5F- AM (ex494/em516 nm,
0.37µM) in culture media for 30min at 37◦C and then incubated
with fresh BSS buffer (1X Hank’s balanced saline solution,
100U/ml penicillin, 100µg/ml streptomycin, 10mM HEPES)
for 3 h at 37◦C. The neuron containing dish was placed on
the confocal microscopy stage with a field having 3–5 slightly
stained neuronal soma. Cells were visualized with argon laser
(488 nm excitation) and the resting state of the fluorescence was
recorded every 1 s for 1min. Each cell body was circled as a
region of interest (ROI) and the total intensity of a ROI for the
first 1min was averaged and defined as F0. Stx2 (3.45µM in
2µl volume) was added close to the imaging site after 1min and
the field was continuously recorded for a total recording time
of 20min. After Stx2 addition, the total intensity was defined
as F, and this was normalized to F0. In experiments using
inhibitors such as Wortmannin (final concentration 100 nM,
EMD Millipore, Billerica, MA) or MK-801 (final concentration
20µM, Sigma-Aldrich), these were added to the BSS buffer, or
alternatively MK-801 was added simultaneously with Stx2 while
imaging.
Phosphorylated Kinase Array
Phospho-array assay (Proteome Profiler Antibody Array,
R&D systems, Minneapolis, MN) was performed on neuronal
lysates as per the manufacturer’s instruction. Phospho-array
is an antibody pre-spotted polyvinylidene fluoride (PVDF)
membrane with 26 Phosphorylated-mitogen-activated protein
kinases (MAPKs)-specific antibodies including p38, c-Jun
N-terminal kinases (JNKs), protein kinase B (PKB/Akt),
cAMP response element-binding protein (CREB), ribosomal
s6 kinase (RSK), mechanistic target of rapamycin (mTOR),
glycogen synthase kinase 3 beta (GSK3β) and extracellular-
signal-regulated kinase (ERK)1/2. Neuronal cultures were
treated with or without 1 nM Stx2 for 2 h at 37◦C and lysates
were made with RIPA buffer consisting 50mM Tris, 150mM
NaCl, 1% igepal CA-630, 0.5% deoxycholic acid supplemented
with protease inhibitor cocktail (all from Sigma-Aldrich),
phenylmethanesulfonylfluoride (PMSF) (Roche, Nutley, NJ),
orthovanadate and serine/threonine protein phosphatase
inhibitor cocktail (EMD Millipore). Lysates were incubated with
horseradish peroxidase-conjugated anti-phospho-antibody and
applied to MAPK-specific antibody-bound PVDF membrane.
ECL method was used to visualize positive signals (Amersham
ECL Western blotting detection reagents, GE Healthcare Life
Sciences, Pittsburgh, PA). The ECL reagent-treated phospho
arrays were exposed to films which were scanned, and the
chemiluminescent signals were quantified using ImagePro Plus
(Media Cybernetics, Rockville, MD).
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TUNEL Staining
We tested Stx2-treated cultured neurons for induction of
apoptosis. Neurons were incubated with 0, 0.1, 1 or 10 nM of
Stx2 for 48 h, and Terminal deoxynucleotidyl transferase dUTP
Nick End Labeling (TUNEL) assay was performed as per the
manufactures (EMD Millipore) instruction. DNase I (37U/well,
GE Healthcare Life Sciences) was used as a positive control,
whereas media alone was used as negative control. TUNEL
positive cells were counted with the aid of an Olympus BX40
(Olympus, Center Valley, PA) microscope using a magnification
of 400x. Ten images per treatment were collected for statistical
analysis, and TUNEL positive as well as total nuclei (methyl green
positive) were counted per image.
We also performed TUNEL assays on CNS tissues from Stx2-
injected mice for in vivo apoptotic evaluation. Mice were injected
with 400 ng/kg Stx2 intraperitoneally and perfuse-fixed cerebral
cortex and lumbar spinal cords were harvested immediately after
injection (0 h) and at 2, 4, 6, 8, 12, 24, 48, or 60 h following
injection. In addition, saline injected controls at 60 h, and
normal (no injection) controls (n = 2 each) were performed.
Tissues were processed and paraffin embedded. TUNEL was
performed as noted above. The motor cortex and the ventral
horn were visualized with 100 X magnification and TUNEL
positive cells were counted (Two imaging fields (right and
left)/section/mouse).
PI/DAPI Staining
Neuron cultures were treated with 0, 0.1, 1, and 10 nM Stx2
for 48 h at 37◦C and further incubated with 0.5µM propidium
idodide (PI, Life Technologies) for 10min at room temperature.
After washing and fixing with 4% PFA/PBS, cells were counter
stained with DAPI. Cells were observed with epifluorescence
microscopy, Olympus BX40. Under 200x magnification in which
approximately 100 cells can be captured, PI positive (red),
and DAPI positive (blue) cells were counted. Ten images were
counted in each treatment.
Statistical Analysis
Student’s t-test was performed to compare control versus Stx2-
treated group. Significance was noted for p-values less than 0.05
using two-tailed analysis. All statistical analyses were performed
using GraphPad Prism software (GraphPad Software, Inc., La
Jolla, CA).
Results
Stx2 Interacts with Neurons Via Surface
Expressed Gb3
In order to visualize direct Stx2-Gb3 interactions, we first
conducted anti-Gb3 stain in neuronal culture to confirm
Gb3 expression on the surface of cultured neurons. Neuronal
cell bodies displayed Gb3 on the surface as confirmed by
confocal microscopy (Figure 1A). In order to resolve Stx2-Gb3
interactions, we applied 3D STORM-TIRF, which allows better
resolution compared to standard confocal microscopy (i.e., 3D
STORM TIRF resolves 20 nm along the x- and y-axes and 50 nm
along the z-axis versus standard confocal microscopy which is
limited to 200 nm resolution). Following a 5min incubation of
neurons with Stx2, localization of Stx2 close to Gb3 was detectable
(Figures 1E,G, a diagram in Figure 1C). Increasing the Stx2
incubation period to 15min resulted in increased contacts of
Stx2 and Gb3 signals which occurred in both clusters as well as
in a tubular structure (Figure 1F, a diagram in Figure 1D). The
tubular structures were formed intracellularly but close to the
cell membrane (Figure 1H) suggesting endocytosis. The distance
from the edge of the Stx2 signal to that of Gb3 was 0.324 ±
0.117µm (n = 21) and 0.680 ± 0.139µm (n = 5), for the
5min and 15min Stx2 incubations respectively (Figure 1B). The
increased distance between Stx2 and Gb3 following the 15min
incubation period suggests a tubular invagination possibly
associated with Stx2 uptake across the neuronal cell membrane.
Stx2 Induces Glutamate Release from the
Synaptic Terminals of Neurons
Effects of Stx2 on neuronal intracellular Ca2+ was determined by
visualization of a Ca2+ indicator dye in live cells. Neurons from
postnatal day 0 (P0) mice were cultured until DIV7 and treated
with Ca2+ indicator fluo-5F-AM. The cells were then imaged
by confocal microscopy for a total of 20min including baseline
recording followed by Stx2 treatment. Individual neuronal
cell bodies were determined as regions of interest (ROI) as
we observed changes in fluorescent intensity in this region
following Stx2 treatment. Each recorded Ca2+-bound fluo-5F-
AM intensity value (F) was divided by baseline average (F0). Stx2
induced a gradual increase in F/F0 as shown in Figure 2A. An
inset in Figure 2A shows F/F0 traces from a control experiment
(without Stx2), and those traces appear much closer to zero than
that from Stx2-treated cells. N-methyl-D-aspartate (NMDA)
receptor is an ionotropic glutamate receptor which allows Ca2+
and Na+ to enter cells when bound by glutamate and glycine
or D-serine. In order to test whether intracellular Ca2+ increase
is due to activation of ionotropic NMDA receptors via Stx2-
mediated glutamate release, we treated neurons with MK-801,
which is a NMDA receptor-specific antagonist and can thereby
block Ca2+ influx (Figure 2D). Neurons were either incubated
with Stx2 and MK-801 simultaneously (BSS_Stx2 + MK) or
pre-incubated with MK-801 before Stx2 addition (MK_Stx2).
The final values of F/F0 were averaged and compared to
Stx2 alone treatment (BSS_Stx2) (Figures 2B,C). When Stx2-
treated samples (BSS_Stx2) were compared to samples with
simultaneous treatment of Stx2 + MK-801 (BSS_Stx2 + MK),
there was a significant reduction of F/F0 in Stx2 +MK-801 (t-test,
∗p = 0.0042). Also, when cells were pre-incubated with MK-801
(MK_Stx2), Stx2-induced F/F0 was significantly reduced in MK-
801 pre-treated cells (Figure 3C, ∗p = 0.0476). The data suggests
that the neurotransmitter released from Stx2-treated neurons is
glutamate, resulting in postsynaptic NMDA-receptor activation
and associated with Ca2+ influx.
The PI3K Signaling Pathway is Involved in
Stx2-induced Glutamate Release in Neurons
In order to determine the signaling pathway that Stx2 utilizes
in neurons, a MAPkinase phospho-array was used to screen
kinases that are phosphorylated in Stx2-treated neurons. Akt
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FIGURE 1 | Stx2 binds to cultured neurons via Gb3. (A) Confocal
microscopy images of anti-Gb3 Ab-AlexaFluor 488 (green, arrows)
showing localization on the surface of neurons (DIV7). An inset shows
merged image of Gb3 localization (green) and differential interference
contrast (DIC). Bar indicates 10µm. (B) Distance from the end of the
green clusters to the beginning of the red clusters (n = 5 per group,
∗p = 0.0007). (C,E,G) A representative STORM-TIRF image from 5min
Stx2-treated neurons. (D,F,H) A contact spot of Stx2 and Gb3 signals
from 15min Stx2 incubated neurons. (C,D) Depiction of indirect
immunofluorescence of Gb3 [primary Ab against Gb3 and anti-rat Ab
conjugated to AlexaFluor 488 (green)] and Stx2 [primary Ab against Stx2
and anti-mouse Ab conjugated to AlexaFluor 647 (red)] shown in cartoon
format. (E,F) The STORM-TIRF images of contact spots from 5min (E)
and 15min (F) incubations (Gb3 in green and Stx2 in red). (G,H) The
depth conversions of (E,F). The depth of the contact is color-coded from
intracellular signal localization in blue (maximum depth of 500 nm) to
extracellular localization in red (minimum depth of -500 nm) in continuous
gradations where 0 nm (purple) indicates the focused plane (plasma
membrane). An upward arrow in (G) shows intracellular direction (cell) and
a downward arrow shows extracellular direction (glass).
(subtypes Akt 1 and 3) and GSK3β were found phosphorylated
after 2 h of Stx2 treatment (Figures 3A,B). Because Akt and
GSK3β are known downstream molecules of the PI3K pathway,
and GSK3β is associated with neurotransmitter release (Zhu
et al., 2007), neurons were pre-incubated with a PI3K-specific
inhibitor Wortmannin, and intracellular calcium was measured
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FIGURE 2 | Stx2 induces glutamate release from neurons. Neurons
were incubated with Ca2+ indicator dye FM5f-AM for 30min at 37◦C, 5%
CO2, and incubated with BSS buffer with or without NMDA receptor
antagonist MK-801 (MK) for 3 h. A confocal microscope LSM510 was used
to visualize faintly stained cells with Argon laser (488 nm emission). (A) Live
cell observation was started at 0 s, and Stx2 was added at 60 s and
fluorescence was recorded until 1200 s. Neuronal cell bodies were
determined as regions of interest. The baseline recordings from 0 to 60s
were averaged and expressed as F0. For each recording point, fluorescence
(F) was divided by F0 to calculate fold change (F/F0) and plotted. An inset
shows traces of control neurons without Stx2. (B) Stx2 alone (n = 7) and
Stx2 + MK (n = 4) added samples were compared their final F/F0 values at
1200 s. (C) Cells were incubated with (n = 9) or without (n = 7) MK and
recorded as in (A) and analyzed as in (B). In (B,C), Student’s t-test was
performed. (D) A schematic presentation of Stx2-induced glutamate release
and affected NMDA receptor. Glutamate is secreted from presynapse and
binds to NMDA-receptors by which Ca2+ channels open, causing influx of
detectable Ca2+. MK-801 binds to opened channel to block Ca2+ influx.
upon Stx2 addition. Wortmannin reduced F/F0 in Stx2-treated
neurons suggesting the PI3K signaling pathway is involved in
Stx2-induced glutamate release (Figure 3C).
Stx2 Induces Neuronal Death in Vitro but Not in
Vivo
High calcium influx induced by an excess glutamate is known
to promote excitotoxicity by mechanisms including apoptosis
(Yang et al., 2014). Also, we and others have shown in other
cell types in vivo and in vitro that Stx2 can promote apoptosis
(Kiyokawa et al., 1998; Jones et al., 2000; Kojio et al., 2000;
Fujii et al., 2003, 2008; Wilson et al., 2005; Creydt et al., 2006;
Stone et al., 2012; Dettmar et al., 2014), and therefore, we
investigated in vitro and in vivo, whether Stx2 induced apoptosis
in neurons. Stx2-induced apoptosis was measured by TUNEL
stain. In vitro, TUNEL positivity was increased by Stx2 in a
dose dependent manner suggesting Stx2 increases apoptotic cell
death in neurons (Figure 4A), and PI/DAPI staining further
confirmed these results (Figure 4B). While TUNEL assay detects
DNA fragmentation that occurs during apoptotic cell death,
the PI/DAPI assay is based on high impermeability of PI to
nucleic membrane that PI nuclei stain only occurs when the
membrane is irreversibly impaired (Wu et al., 2009), and does
not distinguish between apoptosis and necrosis. Overall, both
assays demonstrated that Stx2-treatment induced neuronal death
in vitro. Contrarily, in vivo studies in mice where mice were
administered 2LD50 dose of Stx2 intraperitoneally, we were
unable to detect TUNEL positive neurons in the motor nuclei
and the ventral horn of lumbar spinal cord (Table 1) that
are responsible of moving hindlegs despite developing hindleg
paralysis around 60 h of post injection, suggesting Stx2 does not
induce apoptosis in murine neurons in vivo.
Discussion
Previously, we reported that mouse and human neurons express
Gb3 in vivo (Obata et al., 2008). In the current study, we
demonstrate for the first time that cultured murine neurons
express Gb3 and that Stx2 interacts with Gb3 displayed on the
surface of the cell. Moreover, by using 3D STORM-TIRF we
are able to detect the development of an invaginating tubular
structure following Stx2 treatment which was similar to that
reported for the receptor binding subunit of Shiga toxin from
Shigella dysenteriae type I in HeLa cells (Romer et al., 2007).
These data suggest that Stx2 is able to intoxicate neuronal cells
directly in a Gb3 dependent manner and that binding of Stx2 to
Gb3 promotes structural changes in the cell membrane that may
be indicative of early endocytosis.
Next we were able to show that murine neurons treated with
Stx2 developed increased intracellular calcium. The occurrence
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FIGURE 3 | Stx2 induces PI3K-involved signaling pathway to release
glutamate. (A) Phospho-array assay of neuronal lysates showed increased
phosphorylation in Akt after 2 h incubation with 1 nM Stx2 (n = 2/probe). (B)
GSK3β was also increased (n = 2/probe). (A,B) each depict a single example
from a total of three samples. All experiments showed a similar trend. (C)
Neurons were incubated with a PI3K inhibitor Wortmannin (Wort) and
analyzed by Ca2+ imaging. Wortmannin significantly decreased
Stx2-induced intracellular Ca2+ (BSS n = 7 and Wort n = 4, Student’s
t-test). (D) A schematic presentation of the proposed Stx2-induced
PI3K/Akt/GSK3β pathway leading to neurotransmitter (glutamate) release.
FIGURE 4 | Stx2 induces apoptotic cell death in vitro. Neurons were
incubated with different concentrations of Stx2 for 48 h and assayed with
TUNEL stain (n = 20/group) (A) and propidium idodide (PI)/DAPI stain
(n = 5/group) (B). TUNEL positive nuclei (dark brown, black arrowheads)
numbers were normalized by counter stained total nuclei numbers and
expressed as percent TUNEL positive. In PI/DAPI stain, the percentage of PI
positive nuclei (Red, white arrowheads) per total (DAPI positive, blue) nuclei
was calculated. One-Way ANOVA followed by Tukey test, ∗p < 0.05.
of this gradual Ca2+ increase had us hypothesize that it could
be triggered by Stx2-induced secondary factor such as glutamate
release rather than direct ion channel opening by Stx2 To
this extent we inhibited a subtype of ionotropic glutamate
receptor, NMDA receptor with MK-801, which reduced Stx2-
induced [Ca2+]i increase, suggesting that synaptic glutamate
release was contributing to the observed Stx2-mediated [Ca2+]i
increase. A previous study had shown that Shiga toxin type 1
induced PI3K/Akt signaling which was associated with Ca2+
signaling and phosphorylation of GSK3α/β in macrophage-like
THP-1 cells (Cherla et al., 2009). Similar to those studies we
observed that Stx2 caused increases in phospho-Akt isoforms
and phospho-GSK3β (Figures 3A,B). The dephosphorylation
of GSK3β has been demonstrated to reduce exocytosis of
neurotransmitter in response to membrane depolarization
in hippocampal neuronal culture (Zhu et al., 2010). Also,
phosphorylation of GSK3β increases synaptic strength due to an
increase in glutamate release (Hooper et al., 2007). To investigate
the involvement of PI3K/Akt/GSK3β pathway in Stx2-induced
glutamate release, we performed Ca2+ imaging assay using
the PI3K inhibitor Wortmannin. Wortmannin-treated cells
significantly reduced Stx2-induced [Ca2+]i (Figure 3C,
∗p <
0.0001). These data indicated that Stx2 induces glutamate release
via the PI3K/Akt/GSK3β pathway. Usage of PI3K/Akt/GSK3β
signaling pathway by Stx is in agreement with Cherla et al. (2009)
in which Stx1 induced proinflammatory cytokine release from
THP-1 cells.
In vitro, Stx2-treated neurons showed TUNEL positivity in
dose dependent manner, and this trend was reproducible in
PI/DAPI viability assay. This suggests that Stx2-induced death
in neurons may be due to glutamate toxicity in vitro. However,
in vivo, we did not observe TUNEL positivity in either neurons
of motor nuclei in the cerebral cortex or motor neurons in the
lumber spinal cord (Table 1). And the absence of neuronal death
was reproducible in Nissl’s stain which was used to evaluate
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TABLE 1 | TUNEL results in spinal cord and cortex of Stx2-injected micea.
TUNEL (+) nuclei
Lumbar spinal cordb Cerebral cortexc
Stx2 (h) Mouse ID Neuron Glia Neuron Glia
0d 597 0 0 0 9
0 598 0 0 n.d.e n.d.
2 599 0 0 n.d. n.d.
2 600 0 0 n.d. n.d.
4 601 0 0 n.d. n.d.
4 602 0 0 n.d. n.d.
6 603 0 0 n.d. n.d.
6 604 0 0 n.d. n.d.
8 605 0 0 n.d. n.d.
8 606 0 0 n.d. n.d.
12 607 0 0 n.d. n.d.
12 608 0 0 n.d. n.d.
24 609 0 0 n.d. n.d.
24 610 0 0 0 5
48 611 0 2 n.d. n.d.
48 612 0 1 n.d. n.d.
60 613 0 0 0 5
60 614 0 0 n.d. n.d.
saline 60f 615 0 0 0 9
saline 60 616 0 0 0 5
normalg 617 0 0 0 5
normal 618 0 0 n.d. n.d.
aOne field of 200 X magnification per mouse was counted.
bVentral horn including motor neurons.
cMotor nuclei.
dStx2 (2LD50) was injected i.p. and sacrificed subsequently.
eN.d., not determined.
fSacrificed after 60 h of saline injection.
gNo injection control.
general numbers of neurons (data not shown). In vivo, astrocytic
end feet are usually surrounding synapses and contributing to
scavenge presynaptically secreted excess glutamates via glutamate
transporters to reduce excitotoxicity (Kawahara et al., 2002;
Wisman et al., 2003). Thus, we speculate that it is possible in vivo,
synapses may be initially protected by astrocytic glutamate
scavenging function and Stx2-induced neuronal toxicity is
avoided. However, during Stx2-induced hindlimb paralysis later
in the time course, we observed that synapses surrounding motor
neurons are interrupted by astrocytic end feet (Obata et al., 2008).
This suggests association of astrocytes in Stx2-induced CNS
dysfunction in vivo. Future studies of Stx2-affected neurons and
astrocytes should help elucidate whether Stx2-induced glutamate
release contributes to hindlimb paralysis and CNS impairment
in vivo.
Acknowledgments
We appreciate Dr. Koujiro Tohyama (Iwate Medical University,
Japan) for helpful discussion. We also thank Dr. Ola Awad
for her expert opinion on cell death experiment. This
work was supported by NIH grant AI075778 and AI09014
4 to FO.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnmol.
2015.00030
Supplementary Video S1 | 3D STORM-TIRF yellow cluster movie. Green
denotes Gb3 and red denotes Stx2.
Supplementary Video S2 | 3D STORM-TIRF yellow cluster depth view
movie. The distribution of the molecules in Supplementary Video S1 is color
coded according to the depth color bar.
References
Bale, J. F. Jr., Brasher, C., and Siegler, R. L. (1980). CNS manifestations
of the hemolytic-uremic syndrome. Relationship to metabolic
alterations and prognosis. Am. J. Dis. Child 134, 869–872. doi:
10.1001/archpedi.1980.02130210053014
Brasher, C., and Siegler, R. L. (1981). The hemolytic-uremic syndrome. West. J.
Med. 134, 193–197.
Cherla, R. P., Lee, S. Y., Mulder, R. A., Lee, M. S., and Tesh, V. L. (2009).
Shiga toxin 1-induced proinflammatory cytokine production is regulated by the
phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling
pathway. Infect. Immun. 77, 3919–3931. doi: 10.1128/IAI.00738-09
Cimolai, N., Morrison, B. J., and Carter, J. E. (1992). Risk factors for the central
nervous system manifestations of gastroenteritis-associated hemolytic-uremic
syndrome. Pediatrics 90, 616–621.
Creydt, V. P., Silberstein, C., Zotta, E., and Ibarra, C. (2006). Cytotoxic
effect of Shiga toxin-2 holotoxin and its B subunit on human renal
tubular epithelial cells. Microbes Infect. 8, 410–419. doi: 10.1016/j.micinf.2005.
07.005
Dettmar, A. K., Binder, E., Greiner, F. R., Liebau, M. C., Kurschat, C. E.,
Jungraithmayr, T. C., et al. (2014). Protection of human podocytes from
shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases
and apoptosis by human serum amyloid P component. Infect. Immun. 82,
1872–1879. doi: 10.1128/IAI.01591-14
Donohue-Rolfe, A., Acheson, D. W., Kane, A. V., and Keusch, G. T. (1989).
Purification of Shiga toxin and Shiga-like toxins I and II by receptor
analog affinity chromatography with immobilized P1 glycoprotein and
production of cross-reactive monoclonal antibodies. Infect. Immun. 57,
3888–3893.
Fujii, J., Kinoshita, Y., Kita, T., Higure, A., Takeda, T., Tanaka, N., et al.
(1996). Magnetic resonance imaging and histopathological study of brain
lesions in rabbits given intravenous verotoxin 2. Infect. Immun. 64,
5053–5060.
Fujii, J., Matsui, T., Heatherly, D. P., Schlegel, K. H., Lobo, P. I., Yutsudo, T., et al.
(2003). Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect. Immun.
71, 2724–2735. doi: 10.1128/IAI.71.5.2724-2735.2003
Fujii, J., Wood, K., Matsuda, F., Carneiro-Filho, B. A., Schlegel, K. H., Yutsudo,
T., et al. (2008). Shiga toxin 2 causes apoptosis in human brain microvascular
endothelial cells via C/EBP homologous protein. Infect. Immun. 76, 3679–3689.
doi: 10.1128/IAI.01581-07
Garcia, A., Marini, R. P., Catalfamo, J. L., Knox, K. A., Schauer, D. B.,
Rogers, A. B., et al. (2008). Intravenous Shiga toxin 2 promotes enteritis
and renal injury characterized by polymorphonuclear leukocyte infiltration
and thrombosis in Dutch Belted rabbits. Microbes Infect. 10, 650–656. doi:
10.1016/j.micinf.2008.03.004
Gerber, A., Karch, H., Allerberger, F., Verweyen, H. M., and Zimmerhackl, L. B.
(2002). Clinical course and the role of shiga toxin-producing Escherichia coli
infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000,
Frontiers in Molecular Neuroscience | www.frontiersin.org 8 July 2015 | Volume 8 | Article 30
Obata et al. Stx2 induces glutamate release via PI3K
in Germany and Austria: a prospective study. J. Infect. Dis. 186, 493–500. doi:
10.1086/341940
Hooper, C., Markevich, V., Plattner, F., Killick, R., Schofield, E., Engel, T.,
et al. (2007). Glycogen synthase kinase-3 inhibition is integral to long-term
potentiation. Eur. J. Neurosci. 25, 81–86. doi: 10.1111/j.1460-9568.2006.05245.x
Iijima, K., Kamioka, I., and Nozu, K. (2008). Management of diarrhea-associated
hemolytic uremic syndrome in children. Clin. Exp. Nephrol. 12, 16–19. doi:
10.1007/s10157-007-0007-4
Jandhyala, D. M., Vanguri, V., Boll, E. J., Lai, Y., Mccormick, B. A., and Leong,
J. M. (2013). Shiga toxin-producing Escherichia coli O104:H4: an emerging
pathogen with enhanced virulence. Infect. Dis. Clin. North Am. 27, 631–649.
doi: 10.1016/j.idc.2013.05.002
Jones, N. L., Islur, A., Haq, R., Mascarenhas, M., Karmali, M. A., Perdue, M. H.,
et al. (2000). Escherichia coli Shiga toxins induce apoptosis in epithelial cells
that is regulated by the Bcl-2 family. Am. J. Physiol. Gastrointest. Liver Physiol.
278, G811–G819. Available online at: http://ajpgi.physiology.org/content/278/
5/G811.full-text.pdf+html
Kawahara, K., Hosoya, R., Sato, H., Tanaka, M., Nakajima, T., and Iwabuchi,
S. (2002). Selective blockade of astrocytic glutamate transporter GLT-1
with dihydrokainate prevents neuronal death during ouabain treatment of
astrocyte/neuron cocultures. Glia 40, 337–349. doi: 10.1002/glia.10133
Kiyokawa, N., Taguchi, T., Mori, T., Uchida, H., Sato, N., Takeda, T., et al.
(1998). Induction of apoptosis in normal human renal tubular epithelial cells
by Escherichia coli Shiga toxins 1 and 2. J. Infect. Dis. 178, 178–184. doi:
10.1086/515592
Kojio, S., Zhang, H., Ohmura, M., Gondaira, F., Kobayashi, N., and Yamamoto,
T. (2000). Caspase-3 activation and apoptosis induction coupled with the
retrograde transport of shiga toxin: inhibition by brefeldin A. FEMS Immunol.
Med. Microbiol. 29, 275–281. doi: 10.1111/j.1574-695X.2000.tb01534.x
Magnus, T., Rother, J., Simova, O., Meier-Cillien, M., Repenthin, J., Moller, F.,
et al. (2012). The neurological syndrome in adults during the 2011 northern
German E. coli serotype O104:H4 outbreak. Brain 135, 1850–1859. doi:
10.1093/brain/aws090
Mizuguchi, M., Tanaka, S., Fujii, I., Tanizawa, H., Suzuki, Y., Igarashi, T.,
et al. (1996). Neuronal and vascular pathology produced by verocytotoxin
2 in the rabbit central nervous system. Acta Neuropathol. 91, 254–262. doi:
10.1007/s004010050423
Oakes, R. S., Siegler, R. L., McReynolds, M. A., Pysher, T., and Pavia, A. T. (2006).
Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics
117, 1656–1662. doi: 10.1542/peds.2005-0785
Obata, F., and Obrig, T. (2014). Role of Shiga/Vero toxins in pathogenesis.
Microbiol. Spectr. 2. doi: 10.1128/microbiolspec.EHEC-0005-2013
Obata, F., Tohyama, K., Bonev, A. D., Kolling, G. L., Keepers, T. R., Gross, L. K.,
et al. (2008). Shiga toxin 2 affects the central nervous system through receptor
globotriaosylceramide localized to neurons. J. Infect. Dis. 198, 1398–1406. doi:
10.1086/591911
Romer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., et al.
(2007). Shiga toxin induces tubular membrane invaginations for its uptake into
cells. Nature 450, 670–675. doi: 10.1038/nature05996
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.
A., Roy, S. L., et al. (2011). Foodborne illness acquired in the United
States–major pathogens. Emerging Infect. Dis. 17, 7–15. doi: 10.3201/eid1701.
P11101
Sheth, K. J., Swick, H. M., and Haworth, N. (1986). Neurological
involvement in hemolytic-uremic syndrome. Ann. Neurol. 19, 90–93. doi:
10.1002/ana.410190120
Siegler, R. L. (1994). Spectrum of extrarenal involvement in postdiarrheal
hemolytic-uremic syndrome. J. Pediatr. 125, 511–518. doi: 10.1016/S0022-
3476(94)70001-X
Siegler, R. L., Pavia, A. T., Christofferson, R. D., and Milligan, M. K. (1994). A 20-
year population-based study of postdiarrheal hemolytic uremic syndrome in
Utah. Pediatrics 94, 35–40.
Stone, S. M., Thorpe, C. M., Ahluwalia, A., Rogers, A. B., Obata, F., Vozenilek,
A., et al. (2012). Shiga toxin 2-induced intestinal pathology in infant
rabbits is A-subunit dependent and responsive to the tyrosine kinase and
potential ZAK inhibitor imatinib. Front. Cell. Infect. Microbiol. 2:135. doi:
10.3389/fcimb.2012.00135
Sugatani, J., Igarashi, T., Munakata, M., Komiyama, Y., Takahashi, H., Komiyama,
N., et al. (2000). Activation of coagulation in C57BL/6 mice given verotoxin 2
(VT2) and the effect of co-administration of LPS with VT2. Thromb. Res. 100,
61–72. doi: 10.1016/S0049-3848(00)00305-4
Takahashi, K., Funata, N., Ikuta, F., and Sato, S. (2008). Neuronal apoptosis
and inflammatory responses in the central nervous system of a rabbit
treated with Shiga toxin-2. J. Neuroinflammation 5:11. doi: 10.1186/1742-
2094-5-11
Taylor, C. M., White, R. H., Winterborn, M. H., and Rowe, B. (1986).
Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West
Midlands. Br. Med. J. (Clin. Res. Ed.). 292, 1513–1516. doi: 10.1136/bmj.292.
6534.1513
Tironi-Farinati, C., Loidl, C. F., Boccoli, J., Parma, Y., Fernandez-Miyakawa,
M. E., and Goldstein, J. (2010). Intracerebroventricular Shiga toxin
2 increases the expression of its receptor globotriaosylceramide and
causes dendritic abnormalities. J. Neuroimmunol. 222, 48–61. doi:
10.1016/j.jneuroim.2010.03.001
Tzipori, S., Chow, C. W., and Powell, H. R. (1988). Cerebral infection with
Escherichia coli O157:H7 in humans and gnotobiotic piglets. J. Clin. Pathol. 41,
1099–1103. doi: 10.1136/jcp.41.10.1099
Upadhyaya, K., Barwick, K., Fishaut, M., Kashgarian, M., and Siegel, N. J. (1980).
The importance of nonrenal involvement in hemolytic-uremic syndrome.
Pediatrics 65, 115–120.
Verweyen, H. M., Karch, H., Allerberger, F., and Zimmerhackl, L. B. (1999).
Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic
syndrome: a prospective study in Germany and Austria. Infection 27, 341–347.
doi: 10.1007/s150100050040
Werber, D., King, L. A., Muller, L., Follin, P., Buchholz, U., Bernard, H., et al.
(2013). Associations of age and sex with the clinical outcome and incubation
period of Shiga toxin-producing Escherichia coliO104:H4 infections, 2011.Am.
J. Epidemiol. 178, 984–992. doi: 10.1093/aje/kwt069
Wilson, C., Foster, G. H., and Bitzan, M. (2005). Silencing of Bak ameliorates
apoptosis of human proximal tubular epithelial cells by Escherichia coli-
derived Shiga toxin 2. Infection 33, 362–367. doi: 10.1007/s15010-00
5-5073-5
Wisman, L. A., van Muiswinkel, F. L., de Graan, P. N., Hol, E. M., and Bar, P.
R. (2003). Cells over-expressing EAAT2 protect motoneurons from excitotoxic
death in vitro. Neuroreport 14, 1967–1970. doi: 10.1097/00001756-200310270-
00017
Wu, C. L., Hwang, C. S., and Yang, D. I. (2009). Protective effects of brain-
derived neurotrophic factor against neurotoxicity of 3-nitropropionic
acid in rat cortical neurons. Neurotoxicology 30, 718–726. doi:
10.1016/j.neuro.2009.03.008
Yang, L., Yang, Z. M., Zhang, N., Tian, Z., Liu, S. B., and Zhao, M. G. (2014).
Neuroprotective effects of vitexin by inhibition of NMDA receptors in primary
cultures of mouse cerebral cortical neurons. Mol. Cell. Biochem. 386, 251–258.
doi: 10.1007/s11010-013-1862-9
Zhu, L. Q., Liu, D., Hu, J., Cheng, J., Wang, S. H., Wang, Q., et al. (2010). GSK-
3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type
calcium channel and interrupting SNARE complex formation. J. Neurosci. 30,
3624–3633. doi: 10.1523/JNEUROSCI.5223-09.2010
Zhu, L. Q., Wang, S. H., Liu, D., Yin, Y. Y., Tian, Q., Wang, X. C., et al. (2007).
Activation of glycogen synthase kinase-3 inhibits long-term potentiation
with synapse-associated impairments. J. Neurosci. 27, 12211–12220. doi:
10.1523/JNEUROSCI.3321-07.2007
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Obata, Hippler, Saha, Jandhyala and Latinovic. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 July 2015 | Volume 8 | Article 30
